the effects of naloxone ( 0.4 mg , i.m . ) , of 2-br-alpha-ergocryptine ( cb154 , 2.5 mg , p.o . ) and of the interaction between cb154 and naloxone on growth hormone ( gh ) and prolactin ( prl ) secretion were studied in 11 acromegalic patients .
C0006230
2-br-alpha-ergocryptine
C0001206
acromegalic